Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
151 - 175 out of 509Page size: 25
  1. 2022
  2. Published

    Microalbuminuria Constitutes a Clinical Action Item for Clinicians in 2021

    Rossing, Peter & Epstein, M., 2022, In: American Journal of Medicine. 135, 5, p. 576-580 5 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

    Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomes

    Schnell, O., Battelino, T., Bergenstal, R., Blüher, M., Böhm, M., Brosius, F., Carr, R. D., Ceriello, A., Forst, T., Giorgino, F., Guerci, B., Heerspink, H. J. L., Itzhak, B., Ji, L., Kosiborod, M., Lalić, N., Lehrke, M., Marx, N., Nauck, M., Rodbard, H. W. & 10 others, Rosano, G. M. C., Rossing, Peter, Rydén, L., Santilli, F., Schumm-Draeger, P., Vandvik, P. O., Vilsbøll, Tina, Wanner, C., Wysham, C. & Standl, E., 2022, In: Cardiovascular Diabetology. 21, 1, 50.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

    Shaman, A. M., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Mann, J. F. E., Nauck, M. A., Rasmussen, S., Rossing, Peter, Wolthers, B., Zinman, B. & Perkovic, V., 2022, In: Circulation. 145, 8, p. 575-585 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial

    Sivalingam, S., Hein Zobel, E., Hansen, C. S., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Jensen, Jacob Kildevang, Hansen, T. W. & Rossing, Peter, 2022, In: Diabetes, Obesity and Metabolism. 24, 8, p. 1638-1642

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease

    Smeijer, J. D., Koomen, J. V., Kohan, D. E., McMurray, J. J. V., Bakris, G. L., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Makino, H., Mayer, G., Nowicki, M., Perkovic, V., Rossing, Peter, Tobe, S., Parving, H. H., de Zeeuw, D. & Heerspink, H. J. L., 2022, In: Clinical Pharmacology and Therapeutics. 112, 5, p. 1098-1107

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes

    Stougaard, E. B., Rossing, Peter, Vistisen, D., Banks, P., Girard, M., Davies, M. J. & Persson, F., 2022, In: Diabetologia. 65, SUPPL 1, p. S47 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  11. Published

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis

    Stougaard, E. B., Kristensen, Peter Lommer, Kielgast, U., Andersen, H. U., Hamid, Y., Gæde, P. H., Søndergaard, E., Dørflinger, G. H., Fjeldborg, K. K., Hansen, K. W., Thomsen, H. H., Al-Imar, T. M. J., Røder, M., Sridhar, V. S., Cherney, D., Rossing, Peter & Persson, F., 2022, In: Diabetes & vascular disease research. 19, 5, p. 14791641221130043

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines

    Stougaard, E. B., Rossing, Peter, Cherney, D., Vistisen, D. & Persson, F., 2022, In: Journal of Diabetes and its Complications. 36, 8, 108257.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Tougaard, N. H., Frimodt-Møller, M., Salmenkari, H., Stougaard, E. B., Zawadzki, A. D., Mattila, I. M., Hansen, T. W., Legido-Quigley, C., Hörkkö, S., Forsblom, C., Groop, P. H., Lehto, M. & Rossing, Peter, 2022, In: Journal of Clinical Medicine. 11, 13, 3573.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

    Tougaard, N. H., Møller, A. L., Rønn, P. F., Hansen, T. W., Genovese, F., Karsdal, M. A., Rasmussen, D. G. K. & Rossing, Peter, Nov 2022, In: Diabetes Care. 45, 11, p. 2746-2748 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions

    Vart, P., Correa-Rotter, R., Hou, F. F., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Douthat, W., Escudero, E., Isidto, R., Khullar, D., Bajaj, H. S., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Kidney International Reports. 7, 4, p. 699-707 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Waijer, S. W., Vart, P., Cherney, D. Z. I., Chertow, G. M., Jongs, N., Langkilde, A. M., Mann, J. F. E., Mosenzon, O., McMurray, J. J. V., Rossing, Peter, Correa-Rotter, R., Stefansson, B. V., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2022, In: Diabetologia. 65, 7, p. 1085-1097 13 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

    Waijer, S. W., Provenzano, M., Mulder, S., Rossing, Peter, Persson, F., Perkovic, V. & Heerspink, H. J. L., 2022, In: Diabetes, Obesity and Metabolism. 24, 6, p. 983-990 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial

    Wheeler, D. C., Jongs, N., Stefansson, B., Chertow, G. M., Greene, T., Hou, F. F., Langkilde, A. M., McMurray, J. J., Rossing, Peter, Nowicki, M., Wittmann, I., Correa-Rotter, R., Sjostrom, C. D., Toto, R. D., Heerspink, H. J. L. & DAPA-CKD Trial Comm Investigators, D. T. C. I., 2022, In: Nephrology Dialysis Transplantation. 37, 9, p. 1647–1656 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Differential and shared genetic effects on kidney function between diabetic and non-diabetic individuals

    Winkler, T. W., Rasheed, H., Teumer, A., Gorski, M., Rowan, B. X., Stanzick, K. J., Thomas, L. F., Tin, A., Hoppmann, A., Chu, A. Y., Tayo, B., Thio, C. H. L., Cusi, D., Chai, J-F., Sieber, K. B., Horn, K., Li, M., Scholz, M., Cocca, M., Wuttke, M. & 31 others, van der Most, P. J., Yang, Q., Ghasemi, S., Nutile, T., Li, Y., Pontali, G., Günther, F., Dehghan, A., Correa, A., Parsa, A., Feresin, A., de Vries, A. P. J., Zonderman, A. B., Smith, A. V., Oldehinkel, A. J., De Grandi, A., Rosenkranz, A. R., Franke, A., Teren, A., Metspalu, A., Hicks, A. A., Morris, A. P., Tönjes, A., Morgan, A., Podgornaia, A. I., Christensen, K., Lind, L., Kovacs, P., Rossing, Peter, Loos, Ruth & LifeLines Cohort Study, L. C. S., 2022, In: Communications Biology . 5, p. 580 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

    Wolsk, E., Jürgens, M., Schou, Morten, Ersbøll, M., Hasbak, P., Kjær, Andreas, Zerahn, B., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Kistorp, Caroline Michaela Nervil & Gustafsson, Finn, 2022, In: Diabetes. 71, 4, p. 812-820 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes: A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Wretlind, A., Zobel, E. H., De Zawadzki, A., Ripa, Rasmus Sejersten, Curovic, V. R., Von Scholten, B. J., Mattila, I. M., Hansen, T. W., Kjær, Andreas, Vestergaard, H., Rossing, Peter & Legido-Quigley, C., 2022, In: Frontiers in Clinical Diabetes and Healthcare. 3, 8 p., 856485.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

    Zobel, E. H., von Scholten, B. J., Hansen, T. W., Persson, F., Rasmussen, S., Wolthers, B. & Rossing, Peter, Feb 2022, In: Diabetes, Obesity and Metabolism. 24, 2, p. 281-288 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Diabetes Care. 45, 12, p. 3075-3090

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Kidney International. 102, 5, p. 974-989 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease

    de Boer, I. H., Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Zoungas, S., Jadoul, M., Winkelmayer, W. C., Tonelli, M. A. & 7 others, Craig, J. C., Strippoli, G. F. M., Tunnicliffe, D. J., Higgins, G. Y., Natale, P., Cooper, T. E. & Willis, N. S., 2022, In: Kidney International. 102, 5, p. S1-S127 127 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice

    von Scholten, B. J., Kreiner, F. F., Rasmussen, S., Rossing, Peter & Idorn, T., 2022, In: Therapeutic Advances in Endocrinology and Metabolism. 13, p. 1-14

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...21 Next

ID: 12937790